StockData
Ardent Health, Inc. logo

Ardent Health, Inc. (ARDT) stock

ARDTNYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 8/3036% below fair value
$12.03−0.27 (-2.20%)

Close on Oct 30, 2026Market cap $1.70BP/E 21.9Yield –

Earnings

Ardent Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 11, 2026
Q3 FY2026 · estimated, during market hours
Revenue, Q2 FY2026
$1.62B
-1.5% on a year earlier
Adjusted diluted EPS, Q2 FY2026
$0.12
$0.52 a year earlier
Latest guidance
Lowered
Aug 4, 2026 · 6 items

Quarterly results

Revenue and earnings per share from each of Ardent Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q3 FY2026ended Sep 30, 2026Nov 11, 2026Expected–––––
Q2 FY2026ended Jun 30, 2026Aug 4, 2026during market hours$1.62B-1.5%$0.12$0.12Release
Q1 FY2026ended Mar 31, 2026May 5, 2026during market hours$1.60B+7.0%$0.28–Release
Q4 FY2025ended Dec 31, 2025Mar 4, 2026during market hours$1.61B-0.1%$0.32–Release
Q3 FY2025ended Sep 30, 2025Nov 12, 2025during market hours$1.58B+8.8%-$0.17–Release
Q2 FY2025ended Jun 30, 2025Aug 5, 2025during market hours$1.65B+11.9%$0.52–Release
Q1 FY2025ended Mar 31, 2025May 6, 2025during market hours$1.50B–$0.29–Release
Q4 FY2024ended Dec 31, 2024Feb 26, 2025during market hours$1.61B–$0.81–Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024during market hours$1.45B–$0.19–Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024during market hours$1.47B–$0.34–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Ardent Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Total revenueFY2026$6.40B – $6.70B$6.40B – $6.70BReaffirmedAug 4, 2026
Adjusted admissions growthFY2026+1.5% – +2.5%–NewMar 4, 2026
Adjusted EBITDAnon-GAAPFY2026$485.00M – $535.00M$485.00M – $535.00MReaffirmedAug 4, 2026
Diluted earnings per shareGAAPFY2026$0.78 – $1.15$0.90 – $1.27LoweredAug 4, 2026
Capital expendituresFY2026$225.00M – $265.00M$225.00M – $265.00MReaffirmedAug 4, 2026
Adjusted admissions growthFY2026+1.5% – +2.5%+1.5% – +2.5%ReaffirmedAug 4, 2026
Net income attributable to Ardent Health, Inc.FY2026$129.00M – $183.00M$129.00M – $183.00MLoweredMay 5, 2026
Rent expense payable to REITsFY2026$168.00M$168.00MReaffirmedAug 4, 2026

Guidance vs results

The last range Ardent Health gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025EPS (GAAP)$0.85 – $1.03$0.96Σ4QWithin range
FY2025Revenue$6.20B – $6.45B$6.32BΣ4QWithin range

Guidance history

Every forecast Ardent Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Aug 4, 2026Capital expendituresFY2026$225.00M – $265.00MReaffirmed
Aug 4, 2026Adjusted EBITDAFY2026$485.00M – $535.00MReaffirmed
Aug 4, 2026Diluted earnings per shareFY2026$0.78 – $1.15Lowered
Aug 4, 2026Rent expense payable to REITsFY2026$168.00MReaffirmed
Aug 4, 2026Adjusted admissions growthFY2026+1.5% – +2.5%Reaffirmed
Aug 4, 2026Total revenueFY2026$6.40B – $6.70BReaffirmed
May 5, 2026Capital expendituresFY2026$225.00M – $265.00MReaffirmed
May 5, 2026Adjusted EBITDAFY2026$485.00M – $535.00MReaffirmed
May 5, 2026Diluted earnings per shareFY2026$0.90 – $1.27Reaffirmed
May 5, 2026Rent expense payable to REITsFY2026$168.00MNarrowed
May 5, 2026Net income attributable to Ardent Health, Inc.FY2026$129.00M – $183.00MLowered
May 5, 2026Adjusted admissions growthFY2026+1.5% – +2.5%New
May 5, 2026Total revenueFY2026$6.40B – $6.70BReaffirmed
Mar 4, 2026Capital expendituresFY2026$225.00M – $265.00MNew
Mar 4, 2026Adjusted admissions growthFY2026+1.5% – +2.5%New
Mar 4, 2026Adjusted EBITDAFY2026$485.00M – $535.00MNew
Mar 4, 2026Diluted earnings per shareFY2026$0.90 – $1.27New
Mar 4, 2026Net income attributable to Ardent Health, Inc.FY2026$129.00M – $183.00MNew
Mar 4, 2026Rent expense payable to REITsFY2026$168.00MNarrowed
Mar 4, 2026Total revenueFY2026$6.40B – $6.70BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Ardent Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. The following sections of “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of
    News
  2. Ardent Health Reports Second Quarter 2026 Results
    Results
  3. Ardent Health Appoints Dave Caspers as CEO
    Update
  4. Ardent Health Reports First Quarter 2026 Results
    Results
  5. Ardent Health Reports Fourth Quarter 2025 Results
    Results
  6. Ardent Health Announces $50 Million Share Repurchase
    Update
  7. Ardent Health Reports Third Quarter 2025 Results
    Results
  8. Ardent Health Reports Second Quarter 2025 Results
    Results
  9. Ardent Health Reports First Quarter 2025 Results
    Results
  10. Quarterly results release
    Results
  11. Quarterly results release
    Results
  12. Ardent Health Reports Third Quarter 2024 Results
    Results
  13. Ardent Health Reports Second Quarter 2024 Results
    Results